South Korea In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published : Dec-2017

No. of Pages : 468

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 9
2 Introduction 14
2.1 What Is This Report About? 14
2.2 In Vitro Diagnostics (IVD) Market Segmentation 14
2.3 Definitions of Markets Covered in the Report 18
3 In Vitro Diagnostics Market, South Korea 41
3.1 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2010-2024 41
3.2 In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2017 43
3.3 In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2017 44
3.4 In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 46
3.5 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2010-2017 48
3.6 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2017-2024 50
3.7 In Vitro Diagnostics Market, South Korea, Volume (Units), 2010-2024 52
3.8 In Vitro Diagnostics Market, South Korea, Volume (Units), 2010-2017 54
3.9 In Vitro Diagnostics Market, South Korea, Volume (Units), 2017-2024 56
3.10 In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), 2017 58
4 Clinical Chemistry Market, South Korea 60
4.1 Clinical Chemistry Market, South Korea, Revenue Mix ($m), 2017 60
4.2 Clinical Chemistry Market, South Korea, Segment Contribution (%), 2017 61
4.3 Clinical Chemistry Market, South Korea, Revenue ($m), 2010-2017 63
4.4 Clinical Chemistry Market, South Korea, Revenue ($m), 2017-2024 65
4.5 Clinical Chemistry Market, South Korea, Volume (Units), 2010-2017 99
4.6 Clinical Chemistry Market, South Korea, Volume (Units), 2017-2024 101
4.7 Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2017 127
4.8 Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), 2017 128
5 Genetic Testing Market, South Korea 130
5.1 Genetic Testing Market, South Korea, Revenue Mix ($m), 2017 130
5.2 Genetic Testing Market, South Korea, Segment Contribution (%), 2017 131
5.3 Genetic Testing Market, South Korea, Revenue ($m), 2010-2017 132
5.4 Genetic Testing Market, South Korea, Revenue ($m), 2017-2024 134
5.5 Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), 2017 136
5.6 Genetic Testing Market, South Korea, Company Share by Revenue ($m), 2017 137
6 Hematology Market, South Korea 139
6.1 Hematology Market, South Korea, Revenue Mix ($m), 2017 139
6.2 Hematology Market, South Korea, Segment Contribution (%), 2017 140
6.3 Hematology Market, South Korea, Revenue ($m), 2010-2017 141
6.4 Hematology Market, South Korea, Revenue ($m), 2017-2024 143
6.5 Hematology Market, South Korea, Volume (Units), 2010-2017 169
6.6 Hematology Market, South Korea, Volume (Units), 2017-2024 171
6.7 Hematology Market, South Korea, Distribution Share by Revenue ($m), 2017 189
6.8 Hematology Market, South Korea, Company Share by Revenue ($m), 2017 190
7 Histology And Cytology Market, South Korea 192
7.1 Histology And Cytology Market, South Korea, Revenue Mix ($m), 2017 192
7.2 Histology And Cytology Market, South Korea, Segment Contribution (%), 2017 193
7.3 Histology And Cytology Market, South Korea, Revenue ($m), 2010-2017 194
7.4 Histology And Cytology Market, South Korea, Revenue ($m), 2017-2024 196
7.5 Histology And Cytology Market, South Korea, Distribution Share by Revenue ($m), 2017 198
7.6 Histology And Cytology Market, South Korea, Company Share by Revenue ($m), 2017 199
8 Immuno Chemistry Market, South Korea 201
8.1 Immuno Chemistry Market, South Korea, Revenue Mix ($m), 2017 201
8.2 Immuno Chemistry Market, South Korea, Segment Contribution (%), 2017 202
8.3 Immuno Chemistry Market, South Korea, Revenue ($m), 2010-2017 204
8.4 Immuno Chemistry Market, South Korea, Revenue ($m), 2017-2024 206
8.5 Immuno Chemistry Market, South Korea, Volume (Units), 2010-2017 240
8.6 Immuno Chemistry Market, South Korea, Volume (Units), 2017-2024 242
8.7 Immuno Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2017 276
8.8 Immuno Chemistry Market, South Korea, Company Share by Revenue ($m), 2017 277
9 Infectious Diagnostics Market, South Korea 279
9.1 Infectious Diagnostics Market, South Korea, Revenue Mix ($m), 2017 279
9.2 Infectious Diagnostics Market, South Korea, Segment Contribution (%), 2017 280
9.3 Infectious Diagnostics Market, South Korea, Revenue ($m), 2010-2017 282
9.4 Infectious Diagnostics Market, South Korea, Revenue ($m), 2017-2024 285
9.5 Infectious Diagnostics Market, South Korea, Volume (Units), 2010-2017 332
9.6 Infectious Diagnostics Market, South Korea, Volume (Units), 2017-2024 335
9.7 Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2017 382
9.8 Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2017 383
10 Microbiology Culture Market, South Korea 385
10.1 Microbiology Culture Market, South Korea, Revenue Mix ($m), 2017 385
10.2 Microbiology Culture Market, South Korea, Segment Contribution (%), 2017 386
10.3 Microbiology Culture Market, South Korea, Revenue ($m), 2010-2017 387
10.4 Microbiology Culture Market, South Korea, Revenue ($m), 2017-2024 389
10.5 Microbiology Culture Market, South Korea, Distribution Share by Revenue ($m), 2017 399
10.6 Microbiology Culture Market, South Korea, Company Share by Revenue ($m), 2017 400
11 Overview of Key Companies in South Korea, In Vitro Diagnostics Market 402
11.1 F. Hoffmann-La Roche Ltd 402
11.2 Abbott Laboratories 402
11.3 Beckman Coulter Inc 402
11.4 Siemens Healthcare GmbH 402
11.5 bioMerieux SA 403
11.6 Thermo Fisher Scientific Inc 403
11.7 Becton Dickinson and Co 403
11.8 Sysmex Corp 403
11.9 Alere Inc 404
11.10 Bio-Rad Laboratories Inc 404
11.11 Cepheid 404
11.12 Qiagen NV 404
11.13 Hologic Inc 405
11.14 Ortho-Clinical Diagnostics Inc 405
12 In Vitro Diagnostics Market Pipeline Products 406
13 Financial Deals Landscape 411
13.1 Acquisition 411
13.2 Asset Transactions 417
13.3 Debt Offerings 419
13.4 Equity Offerings 421
13.5 Partnerships 423
13.6 Private Equity 453
14 Recent Developments 454
14.1 Other Significant Developments 454
14.2 Product News 454
15 Appendix 457
15.1 Research Methodology 458
15.2 GlobalData Consulting 462
15.3 Contact Us 463
15.4 Disclaimer 463

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2010-2024 46
Table 2: In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2017 49
Table 3: In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 51
Table 4: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 53
Table 5: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Table 6: In Vitro Diagnostics Market, South Korea, Volume (Units), 2010-2024 57
Table 7: In Vitro Diagnostics Market, South Korea, Volume (Units), Historic, 2010-2017 59
Table 8: In Vitro Diagnostics Market, South Korea, Volume (Units), Forecast, 2017-2024 61
Table 9: In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 63
Table 10: Clinical Chemistry Market, South Korea, Segment Contribution (%), 2017 66
Table 11: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 68
Table 12: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Table 13: Blood Test Strips - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 72
Table 14: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 74
Table 15: Enzyme Chemistry Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 76
Table 16: Feces Tests - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 78
Table 17: Substrates Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 80
Table 18: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 82
Table 19: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 84
Table 20: Urine Testing - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 86
Table 21: Blood Test Strips - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Table 22: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Table 23: Enzyme Chemistry Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Table 24: Feces Tests - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Table 25: Substrates Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Table 26: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Table 27: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Table 28: Urine Testing - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Table 29: Clinical Chemistry Market, South Korea, Volume (Units), Historic, 2010-2017 104
Table 30: Clinical Chemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 106
Table 31: Blood Test Strips - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 108
Table 32: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 110
Table 33: Enzyme Chemistry Reagents Market, South Korea, Volume (Units), Historic, 2010-2017 112
Table 34: Feces Tests - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 114
Table 35: Substrates Market, South Korea, Volume (Units), Historic, 2010-2017 116
Table 36: Urine Testing - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 118
Table 37: Blood Test Strips - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 120
Table 38: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 122
Table 39: Enzyme Chemistry Reagents Market, South Korea, Volume (Units), Forecast, 2017-2024 124
Table 40: Feces Tests - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 126
Table 41: Substrates Market, South Korea, Volume (Units), Forecast, 2017-2024 128
Table 42: Urine Testing - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 130
Table 43: Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 131
Table 44: Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 133
Table 45: Genetic Testing Market, South Korea, Segment Contribution (%), 2017 135
Table 46: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 137
Table 47: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Table 48: Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 140
Table 49: Genetic Testing Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 142
Table 50: Hematology Market, South Korea, Segment Contribution (%), 2017 144
Table 51: Hematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 146
Table 52: Hematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 148
Table 53: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 150
Table 54: Hematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 152
Table 55: Hematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 154
Table 56: Hematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 156
Table 57: Hemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 158
Table 58: Immunohematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 160
Table 59: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Table 60: Hematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Table 61: Hematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Table 62: Hematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 63: Hemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Table 64: Immunohematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Table 65: Hematology Market, South Korea, Volume (Units), Historic, 2010-2017 174
Table 66: Hematology Market, South Korea, Volume (Units), Forecast, 2017-2024 176
Table 67: Hematology Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 178
Table 68: Hematology Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 180
Table 69: Hematology Reagents Market, South Korea, Volume (Units), Historic, 2010-2017 182
Table 70: Hemostasis Market, South Korea, Volume (Units), Historic, 2010-2017 184
Table 71: Hematology Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 186
Table 72: Hematology Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 188
Table 73: Hematology Reagents Market, South Korea, Volume (Units), Forecast, 2017-2024 190
Table 74: Hemostasis Market, South Korea, Volume (Units), Forecast, 2017-2024 192
Table 75: Hematology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 193
Table 76: Hematology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 195
Table 77: Histology And Cytology Market, South Korea, Segment Contribution (%), 2017 197
Table 78: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 199
Table 79: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Table 80: Histology And Cytology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 202
Table 81: Histology And Cytology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 204
Table 82: Immuno Chemistry Market, South Korea, Segment Contribution (%), 2017 207
Table 83: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 209
Table 84: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Table 85: Complement Deficiency Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 213
Table 86: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 215
Table 87: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 217
Table 88: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 219
Table 89: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 221
Table 90: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 223
Table 91: Immunochemistry Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 225
Table 92: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 227
Table 93: Complement Deficiency Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 229
Table 94: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 231
Table 95: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 233
Table 96: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Table 97: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Table 98: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Table 99: Immunochemistry Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Table 100: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Table 101: Immuno Chemistry Market, South Korea, Volume (Units), Historic, 2010-2017 245
Table 102: Immuno Chemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 247
Table 103: Complement Deficiency Tests Market, South Korea, Volume (Units), Historic, 2010-2017 249
Table 104: Diabetes Assays Market, South Korea, Volume (Units), Historic, 2010-2017 251
Table 105: Disease Specific Immunochemistry Market, South Korea, Volume (Units), Historic, 2010-2017 253
Table 106: Endocrinology Tests Market, South Korea, Volume (Units), Historic, 2010-2017 255
Table 107: IgE Allergy Blood Tests Market, South Korea, Volume (Units), Historic, 2010-2017 257
Table 108: Immunochemistry Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 259
Table 109: Immunochemistry Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 261
Table 110: Vitamins Tests Market, South Korea, Volume (Units), Historic, 2010-2017 263
Table 111: Complement Deficiency Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 265
Table 112: Diabetes Assays Market, South Korea, Volume (Units), Forecast, 2017-2024 267
Table 113: Disease Specific Immunochemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 269
Table 114: Endocrinology Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 271
Table 115: IgE Allergy Blood Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 273
Table 116: Immunochemistry Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 275
Table 117: Immunochemistry Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 277
Table 118: Vitamins Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 279
Table 119: Immuno Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 280
Table 120: Immuno Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 282
Table 121: Infectious Diagnostics Market, South Korea, Segment Contribution (%), 2017 285
Table 122: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 287
Table 123: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 290
Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 293
Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 295
Table 126: Hepatitis Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 297
Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 299
Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 301
Table 129: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 303
Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 305
Table 131: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 307
Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 309
Table 133: Retrovirus Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 311
Table 134: Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 313
Table 135: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 315
Table 136: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 317

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2010-2024 46
Figure 2: In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2017 48
Figure 3: In Vitro Diagnostics Market, South Korea, Category Contribution (%), 2017 49
Figure 4: In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 51
Figure 5: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 53
Figure 6: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 7: In Vitro Diagnostics Market, South Korea, Volume (Units), 2010-2024 57
Figure 8: In Vitro Diagnostics Market, South Korea, Volume (Units), Historic, 2010-2017 59
Figure 9: In Vitro Diagnostics Market, South Korea, Volume (Units), Forecast, 2017-2024 61
Figure 10: In Vitro Diagnostics Market, South Korea, Company Share (%) 2017 63
Figure 11: Clinical Chemistry Market, South Korea, Revenue Mix ($m), 2017 65
Figure 12: Clinical Chemistry Market, South Korea, Segment Contribution (%), 2017 66
Figure 13: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 68
Figure 14: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Figure 15: Blood Test Strips - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 16: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 17: Enzyme Chemistry Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 18: Feces Tests - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 78
Figure 19: Substrates Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 80
Figure 20: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 82
Figure 21: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 84
Figure 22: Urine Testing - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 86
Figure 23: Blood Test Strips - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 24: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 25: Enzyme Chemistry Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 26: Feces Tests - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 27: Substrates Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 28: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 29: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Figure 30: Urine Testing - Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Figure 31: Clinical Chemistry Market, South Korea, Volume (Units), Historic, 2010-2017 104
Figure 32: Clinical Chemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 106
Figure 33: Blood Test Strips - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 108
Figure 34: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 110
Figure 35: Enzyme Chemistry Reagents Market, South Korea, Volume (Units), Historic, 2010-2017 112
Figure 36: Feces Tests - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 114
Figure 37: Substrates Market, South Korea, Volume (Units), Historic, 2010-2017 116
Figure 38: Urine Testing - Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 118
Figure 39: Blood Test Strips - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 120
Figure 40: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 122
Figure 41: Enzyme Chemistry Reagents Market, South Korea, Volume (Units), Forecast, 2017-2024 124
Figure 42: Feces Tests - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 126
Figure 43: Substrates Market, South Korea, Volume (Units), Forecast, 2017-2024 128
Figure 44: Urine Testing - Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 130
Figure 45: Clinical Chemistry Market, South Korea, Company Share (%) 2017 133
Figure 46: Genetic Testing Market, South Korea, Revenue Mix ($m), 2017 135
Figure 47: Genetic Testing Market, South Korea, Segment Contribution (%), 2017 136
Figure 48: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 137
Figure 49: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Figure 50: Genetic Testing Market, South Korea, Company Share (%) 2017 142
Figure 51: Hematology Market, South Korea, Revenue Mix ($m), 2017 144
Figure 52: Hematology Market, South Korea, Segment Contribution (%), 2017 145
Figure 53: Hematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 146
Figure 54: Hematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 148
Figure 55: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 150
Figure 56: Hematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 152
Figure 57: Hematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 154
Figure 58: Hematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 156
Figure 59: Hemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 158
Figure 60: Immunohematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 160
Figure 61: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Figure 62: Hematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Figure 63: Hematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Figure 64: Hematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Figure 65: Hemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Figure 66: Immunohematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Figure 67: Hematology Market, South Korea, Volume (Units), Historic, 2010-2017 174
Figure 68: Hematology Market, South Korea, Volume (Units), Forecast, 2017-2024 176
Figure 69: Hematology Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 178
Figure 70: Hematology Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 180
Figure 71: Hematology Reagents Market, South Korea, Volume (Units), Historic, 2010-2017 182
Figure 72: Hemostasis Market, South Korea, Volume (Units), Historic, 2010-2017 184
Figure 73: Hematology Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 186
Figure 74: Hematology Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 188
Figure 75: Hematology Reagents Market, South Korea, Volume (Units), Forecast, 2017-2024 190
Figure 76: Hemostasis Market, South Korea, Volume (Units), Forecast, 2017-2024 192
Figure 77: Hematology Market, South Korea, Company Share (%) 2017 195
Figure 78: Histology And Cytology Market, South Korea, Revenue Mix ($m), 2017 197
Figure 79: Histology And Cytology Market, South Korea, Segment Contribution (%), 2017 198
Figure 80: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 199
Figure 81: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Figure 82: Histology And Cytology Market, South Korea, Company Share (%) 2017 204
Figure 83: Immuno Chemistry Market, South Korea, Revenue Mix ($m), 2017 206
Figure 84: Immuno Chemistry Market, South Korea, Segment Contribution (%), 2017 207
Figure 85: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 209
Figure 86: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 87: Complement Deficiency Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 213
Figure 88: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 215
Figure 89: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 217
Figure 90: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 219
Figure 91: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 221
Figure 92: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 223
Figure 93: Immunochemistry Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 225
Figure 94: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 227
Figure 95: Complement Deficiency Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 229
Figure 96: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 231
Figure 97: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 233
Figure 98: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Figure 99: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Figure 100: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Figure 101: Immunochemistry Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Figure 102: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Figure 103: Immuno Chemistry Market, South Korea, Volume (Units), Historic, 2010-2017 245
Figure 104: Immuno Chemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 247
Figure 105: Complement Deficiency Tests Market, South Korea, Volume (Units), Historic, 2010-2017 249
Figure 106: Diabetes Assays Market, South Korea, Volume (Units), Historic, 2010-2017 251
Figure 107: Disease Specific Immunochemistry Market, South Korea, Volume (Units), Historic, 2010-2017 253
Figure 108: Endocrinology Tests Market, South Korea, Volume (Units), Historic, 2010-2017 255
Figure 109: IgE Allergy Blood Tests Market, South Korea, Volume (Units), Historic, 2010-2017 257
Figure 110: Immunochemistry Analyzers Market, South Korea, Volume (Units), Historic, 2010-2017 259
Figure 111: Immunochemistry Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 261
Figure 112: Vitamins Tests Market, South Korea, Volume (Units), Historic, 2010-2017 263
Figure 113: Complement Deficiency Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 265
Figure 114: Diabetes Assays Market, South Korea, Volume (Units), Forecast, 2017-2024 267
Figure 115: Disease Specific Immunochemistry Market, South Korea, Volume (Units), Forecast, 2017-2024 269
Figure 116: Endocrinology Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 271
Figure 117: IgE Allergy Blood Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 273
Figure 118: Immunochemistry Analyzers Market, South Korea, Volume (Units), Forecast, 2017-2024 275
Figure 119: Immunochemistry Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 277
Figure 120: Vitamins Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 279
Figure 121: Immuno Chemistry Market, South Korea, Comp

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

South Korea In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model